Abstract

RNA interference (RNAi) is a biological process through which gene expression can be inhibited by RNA molecules with high selectivity and specificity, providing a promising tool for tumor treatment. Two types of molecules are often applied to inactivate target gene expression: synthetic double stranded small interfering RNA (siRNA) and plasmid DNA encoding short hairpin RNA (shRNA). Vectors with high transfection efficiency and low toxicity are essential for the delivery of siRNA and shRNA. In this study, TDAPEI, the synthetic derivative of low-molecular-weight polyethylenimine (PEI), was cross-linked with imine bonds by the conjugation of branched PEI (1.8 kDa) and 2,5-thiophenedicarboxaldehyde (TDA). This biodegradable cationic polymer was utilized as the vector for the delivery of plasmid DNA expressing anti-VEGF-shRNA. Compared to PEI (25 kDa), TDAPEI had a better performance since experimental results suggest its higher transfection efficiency as well as lower toxicity both in cell and animal studies. TDAPEI did not stimulate innate immune response, which is a significant factor that should be considered in vector design for gene delivery. All the results suggested that TDAPEI delivering anti-VEGF-shRNA may provide a promising method for tumor treatment.

Highlights

  • Angiogenesis is an essential prerequisite for the growth and spread of tumors since abundant blood supply is needed to get adequate oxygen and other essential nutrients for tumors to grow rapidly [1, 2]

  • Characteristic IR adsorption peak of imine bonds is at 16901590 cm−1 and a moderate adsorption peak at 1629.62 cm−1 was shown in the spectrum, which indicated that imine bonds were formed and the original aldehyde group disappeared (Figure 1B)

  • The 1H NMR spectrum of TDAPEI in D2O was consistent with our expectation

Read more

Summary

Introduction

Angiogenesis is an essential prerequisite for the growth and spread of tumors since abundant blood supply is needed to get adequate oxygen and other essential nutrients for tumors to grow rapidly [1, 2]. Gene Delivery for Tumor Treatment to be a critical factor contributing to tumor angiogenesis [5, 6]. The inhibition of VEGF expression has been a therapeutic strategy for tumor treatment. RNA interference (RNAi) is a biological process through which gene expression can be inhibited by RNA molecules with high selectivity and specificity, providing a promising tool for tumor treatment [7,8,9]. Many studies have confirmed that RNAi can silence cancer-related genes to inhibit tumor growth [13,14,15], angiogenesis [16,17,18], chemoresistance [19, 20] and metastasis [13, 21, 22]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call